The central nervous system (CNS) is vascularized by a dense capillary network that is critical to deliver oxygen and nutrients, and remove carbon dioxide and waste products, from the neural tissue. These blood vessels contain a series of properties, termed the blood-brain barrier (BBB), which distinguishes them from vasculature in other tissues, enabling CNS vessels to stringently regulate the transfer of ions, molecules and cells between the blood and the tissue. This barrier is critical to maintain brain homeostasis which allows for proper neuronal function and also to protect the tissue from injury and disease and many neurological diseases are associated with BBB dysfunction, including traumatic brain injuries, Alzheimer's disease, stroke, epilepsy, and multiple sclerosis. Therefore, a better understanding of the mechanisms controlling the development of the BBB may lead to improved comprehension of the pathophysiology of these diseases, and further aid in the identification of targets to modulate the barrier to treat different neurological diseases. Many of the properties of the BBB are possessed by the endothelial cells that form the walls of the blood vessels but are acquired through a series of complex cellular interactions with the microenvironment throughout its development. We will review what is known about the induction and regulation of BBB properties during development.
Introduction
The BBB is the name given to a group of characteristics possessed by CNS blood vessels that confers the ability to stringently regulate the transfer of ions, molecules and cells between the blood and the neural tissue. This barrier was first identified following injection of dyes into the blood stream with the observation that these dyes would accumulate in peripheral tissues at a much greater concentration than the CNS. Further electron microscopy studies have identified that in mammals, the barrier is formed by the endothelial cells that make the walls of CNS blood vessels, such that molecular tracers are restricted entry into the CNS both by brain endothelial cell (BEC) paracellular junctions and by a lack of transcellular vesicular routes (Brightman and Reese, 1969; Reese and Karnovsky, 1967) . It is now clear that this widely conserved barrier function is critical both to maintain brain homeostasis, by stringently regulating the extracellular environment of the neural tissue, and to protect the CNS from harmful molecules and pathogens in the blood.
The BECs are intimately associated with numerous neural, vascular and immune cells. These include: pericytes which reside on the abluminal surface of the endothelial tube embedded in the vascular basement membrane; astrocytes, which extend cellular processes that almost completely ensheath the blood vessels; and perivascular macrophages, which monitor the perivascular Virchow-Robins space of larger vessels (Ransohoff, 2009 ). In addition, BECs interact with neurons, microglia as well as other immune cells in the blood and neural tissue (Neuwelt et al., 2008 (Neuwelt et al., , 2011 . The term neurovascular unit (NVU) describes all the components, cellular and molecular, that interact at the critical interface between the blood and the central nervous system which induce and regulate the expression of the BBB phenotype within the brain endothelial cells (Fig. 1) .
After the seminal work identifying BECs as the cell type that forms the BBB, it is now clear that this barrier is defined by a series of different structural, transport, metabolic and adhesion properties that make BECs different from endothelial cells in non-neural tissues. A physical paracellular barrier is created by the presence of tight junctions (TJs) between BECs (Brightman and Reese, 1969) . TJs are the luminal-most cellular junction and are composed of claudins, occludin and zona occludens and seal the paracellular route between BECs creating a high transendothelial cell electrical resistance (TEER) barrier impeding ions and small charged molecules from crossing the BBB (Huber et al., 2001; Reese and Karnovsky, 1967) . These tight junctions create a highly polarized cell, such that BECs have distinct luminal and abluminal membrane composition. These BEC-specific tight junctions are linked with adherens junctions (AJs). Adherens junctions, present in endothelial cells throughout the body, sit abluminal to tight junctions and consist of VE-cadherin dimers that mediate cell-cell membrane adhesion and bind to the actin cytoskeleton via catenins. TJs are more often studied and cited regarding the BBB as they induce a high TEER and reduce Mechanisms of Development 138 (2015) [8] [9] [10] [11] [12] [13] [14] [15] [16] paracellular diffusion to a greater extent than AJs. However, AJs have an important role in peripheral vascular permeability, and also regulate tight junction structure and function in BECs. BECs lack fenestra and undergo extremely low rates of transcytosis compared to peripheral cells creating a transcellular barrier to hydrophilic molecules dissolved in the aqueous solution (Reese and Karnovsky, 1967; Rubin and Staddon, 1999) . These paracellular and transcellular barriers allow the highly polarized cells to regulate the passage of molecules between the blood and the brain by unique transport properties. These transporters generally fall into two categories. First, efflux transporters, such as Pgp and BCRP, are expressed on the luminal membrane and use the energy generated by the hydrolysis of ATP to efflux a wide array of small hydrophobic molecules up their concentration gradients into the blood, thus creating a transport barrier to many small nonpolar molecules that could passively diffuse across the cell membrane (Abbott et al., 2010) . Second, BECs express a series of nutrient transporter that transport highly selective substrates (such as Glut-1/ glucose, Lat-1/amino acids) down their concentration gradients into the brain, thus delivering essential nutrients into the neural tissue (Abbott et al., 2010) . BECs also express very low levels of leucocyte adhesion molecules (LAMs) compared to peripheral endothelial cells, thus limiting CNS immune surveillance by impeding the binding immune cells to BECs and then their migration into the CNS. BECs may also contain unique metabolic properties compared to peripheral tissues, thus metabolizing molecules altering their ability to diffuse or be transported (Bertler et al., 1966; el-Bacha and Minn, 1999) . In order to meet the energetic demand required to maintain BBB integrity, a higher density of mitochondria is observed in BECs compared to peripheral endothelial cells (PECs) (Oldendorf et al., 1977) .
While many studies in the literature use a single method to determine if the BBB is tight or leaky, such as the injection of a single molecular tracer, this is insufficient to truly examine the complexity of the BBB. What is clear is that the BBB is not a single entity, but a large series of properties possessed by BECs with the goal of restricting the movement of non-specific molecules from entering the brain while delivering essential nutrients to the neural tissue, a stringent regulation which is Fig. 1 . The neurovascular unit (NVU) and blood-brain barrier properties. a) The term neurovascular unit (NVU) describes all the components, cellular and molecular, that interact at the critical interface between the blood and central nervous system. Endothelial cells (blue) form the walls of the blood vessels and interact with pericytes (green) embedded in the vascular basement membrane on the ablumenal surface of the vascular tube, which together are ensheathed by astrocytes processes (orange). Neurons (light red), microglia (purple) and perivascular macrophages (at post-capillary venules, not pictured) interact with the vasculature to form the neurovascular unit. b) Endothelial cells are joined by tight junctions (TJs) that create the primary physical paracellular barrier that polarizes the endothelial cells into distinct luminal and abluminal membrane compartments. The TJs consist of a complex network of transmembrane proteins such as claudins (5, 12), occludin and junction adhesion molecules (JAMs). Adherens junctions and TJs are connected to the actin cytoskeleton by ZO-1, -2 and -3. c) The tight paracellular barrier created by TJs allows endothelial transport properties to tightly regulate the movement of molecules between the blood and the brain. Low rates of vesicular transport can also be observed limiting transcellular movement of non-specific molecules from the blood to the brain. Endothelial cells express a variety of transporters, both to efflux potential toxins (Pgp, BCRP, MRPs) and to deliver specific nutrients to the brain (glut-1/glucose; lat-1/amino acids, Mct-1/lactate). critical to maintain brain homeostasis. These BBB properties can be divided into two main classes: 'tight' properties (TJs, efflux transporters, and nutrient transporters), which are enriched in BECs compared to PECs, and 'leaky' properties (transcytosis, LAMs) which BECs lack in comparison with PECs. The size, charge and binding specificity of a given molecule will determine which BBB property or properties are most important for regulating the movement of that molecule between the blood and the brain. Thus to fully understand the function of the BBB, multiple different measures, including the use of different size/ charged tracers, gene expression analysis, and ultrastructural analysis, must be utilized to determine how the BBB may be altered following any situation.
While the properties of the BBB are mainly possessed by the BECs, several lines of evidence have suggested that these properties are not intrinsic to the endothelial cells, but are induced by interactions with the CNS microenvironment. Chick/Quail transplantation studies have identified that neural tissue is able to induce barrier properties in abdominal vessels, whereas brain vessels vascularizing mesodermal tissues lacked the barrier (Janzer and Raff, 1987; Stewart and Wiley, 1981) . Furthermore, purification and culture of BECs result in cellular layers that lack barrier properties, which can be restored by co-culture with neural cells (Rubin et al., 1991) . Taken together these results demonstrate that the neural tissue is required for the induction and maintenance of the BBB phenotype in the endothelial cells.
In the ensuing years, several critical cellular and molecular interactions that regulate the induction of this barrier during development and its maintenance in adulthood have been identified. From the initiation of the angiogenesis in the perineural vascular plexus to the completed formation of the extended CNS vascular network, BBB development is a complex multi-step process involving the interaction of CNS endothelial cells with neural progenitors, pericytes, astrocytes and other neural and immune cells. Many signaling pathways have been identified, however many important questions still remain. Are different BBB properties regulated by the same or different cellular and molecular cues? How are the functions of different properties of the BBB coordinated? Are the signals responsible for the regulation of the BBB inductive signals required for differentiation of the endothelial cells during development, or are they maintenance signals required throughout life, or both? Is BBB dysfunction due to a loss of maintenance cues, or the presence of specific breakdown signals? We will discuss the different cellular and molecular interactions that have been identified which guide CNS-specific angiogenesis, induction, maturation and maintenance of BBB properties (Fig. 2) .
Timing of blood-brain barrier formation during development
Critical to understanding the cellular and molecular regulation of BBB development is identifying the time-period of BBB formation. This has been a controversial subject for years, with the timing of BBB formation difficult to pinpoint. One of the primary issues is that in addition to the BBB, the choroid plexus and the meninges are two further routes of entry into the CNS, and therefore when analyzing tracer studies it is critical to determine the exact route of entry of any tracer utilized. Recent advances in the delivery of tracers to dissected rodent embryos have been used to further pinpoint the timing of BBB formation in these animals.
In mammals, vascularization of the neuroepithelium occurs via sprouting angiogenesis (Risau, 1997) . Endothelial progenitor cells initiate the invasion of the neural tissue from the surrounding perineural vascular plexus and enter into the neuroepithelium in a caudal to cranial direction. Neural progenitor cells secrete molecular signals that drive the migration of the endothelial cells into the neural tissue and during the invasion process endothelial cells secrete cues to recruit pericytes (Hellström et al., 1999) . The formation of these initial blood vessels occurs during early embryogenesis, prior to astrocyte generation. For instance, in rats the first vessels invade the cerebral cortex starting at embryonic day 11 (E11), whereas astrogliogenesis in begins in the cerebral cortex starting at birth (Daneman et al., 2010b; Yang et al., 2013) .
Work using dissected rat embryos has identified that the BBB restricts the movement of small molecules during embryogenesis prior to postnatal astrocyte generation and ensheathment of the vessels (Daneman et al., 2010b) . Further analysis in mice has identified that although the BBB is permeable in the first few days following initiation of angiogenesis, the vessels seal to small molecule tracers within a few days of vessel formation. In particular permeability of BECs is tightly restricted by E15 in mice (Ben-Zvi et al., 2014; Sohet et al., 2015) . Interestingly, in the opossum, a marsupial that is born at a very early developmental stage, small molecules are restricted entry to the CNS by the vessels as soon as they invade the developing CNS (Ek et al., 2006) . The difference in results derived from experiments in the opossum and rodents may be due to technical differences in experimental procedures or differential requirements for BBB development in marsupials exposed to environmental stimuli at earlier developmental timepoints.
Gene expression analysis has revealed that the BECs express TJ proteins, including occludin and claudin-5, at the initiation of angiogenesis as they invade the CNS (Daneman et al., 2009 (Daneman et al., , 2010a . Ultrastructure Neural progenitor cells release Wnt ligands that drive CNS-specific angiogenesis and induce BBB properties. At these early timepoints, the endothelial cells express tight junction proteins and nutrient transporters but also have high levels of vesicle trafficking and express high levels of leucocyte adhesion molecules (LAMs) and plasmalemma vesicle-associated protein (PLVAP). b) As angiogenesis occurs, invading BECs release PDGF-β to recruit pericytes. By secreting different factors including TGF-β, pericytes will repress the expression of "leaky" properties of the BECs, lowering levels of LAMs and PLVAP. Throughout this period, the tight junctions become more elaborate and vesicle trafficking is decreased. c) Astrocytic endfeet are recruited to brain vessels and secret multiples factors as sonic hedgehog (SHH), angiotensinogen (Agt), Angiopoietin (Ang-1) and ApolipoproteinE (ApoE) to increase the expression of BBB properties. P-glycoprotein(PGP) expression is upregulated late in BBB development.
analysis has demonstrated that these early invading endothelial cells have rudimentary TJ strands, but that these strands gain complexity throughout embryogenesis (Wolburg and Lippoldt, 2002) . In addition, nutrient transporters such as glut-1, have been identified to be expressed by early invading endothelial cells (Bolz et al., 1996; Daneman et al., 2010b) . Interestingly, invading endothelial cells have been also shown to possess 'leaky' properties, including, fenestra, large amounts of transcytotic vesicles and the expression of high levels of LAMs (Daneman et al., 2010b; Yoshida et al., 1988) . These leaky properties then decrease within the first few days following the onset of angiogenesis. Therefore, BBB development appears to initiate with the induction of 'tight' properties at the onset of angiogenesis, followed by increasing the complexity of the 'tight' properties and subsequent loss of 'leaky' properties. In addition, resistance measurements have indicated that the paracellular barrier continues to strengthen into the early postnatal periods (Butt et al., 1990) . Furthermore, a large increase in the expression of the efflux transporter has been observed in third postnatal week suggesting continued maturation of the BBB (Daneman et al., 2010b; Ek et al., 2010) . Taken together this timecourse suggests that different properties of the BBB may be regulated by different cellular and molecular mechanisms.
CNS-specific angiogenesis and induction of BBB properties: canonical Wnt pathway
Angiogenesis in mice starts at E9, when endothelial cells invade the neural tissues in response to cues secreted by neural progenitor cells, most notably VEGF. Whereas VEGF is required to drive angiogenesis throughout the body, recent work has identified that there is a unique CNS-specific angiogenic program, requiring Wnt/beta-catenin signaling, that also induces properties of the BBB (Anderson et al., 2011; Cullen et al., 2011; Daneman et al., 2009; Kuhnert et al., 2010; Liebner et al., 2008; Stenman et al., 2008) . Wnt proteins bind to Frizzled receptors to activate different Wnt signaling pathways. The canonical Wnt signaling pathway leads to the stabilization of β-catenin and its accumulation in the nucleus, where β-catenin binds to transcription factors of the lymphoid enhancer factor/T cell factor (Lef/Tcf) family to induce the transcription of target genes (Moon, 2005) . Many Wnt proteins have been identified (19 in the human and as many in mice) and ten different Frizzled receptors have been discovered.
The identification that canonical Wnt signaling was required for BBB induction stemmed from several groups identifying that this signaling pathway was activated specifically in CNS endothelial cells and not in peripheral endothelial cells. In particular, endothelial cell purification and microarray analysis identified that several key downstream effectors of Wnt signaling, including Lef1, Tcf7, Apcdd1 and Axin2, were greatly enriched in CNS endothelial cells compared to peripheral endothelial cells (Daneman et al., 2009 (Daneman et al., , 2010a . Furthermore, use of different transgenic Wnt reporter mice demonstrated that this signaling pathway is indeed activated in CNS endothelial cells, but not peripheral endothelial cells, during the onset of angiogenesis and down-regulated in late embryonic stages (Daneman et al., 2009; Liebner et al., 2008; Maretto et al., 2003; Stenman et al., 2008; .
Genetic disruption of Wnt/beta-catenin signaling leads to severe CNS-specific angiogenesis defects with loss of BBB properties, indicating that CNS angiogenesis and BBB formation are tightly linked (Daneman et al., 2009; Liebner et al., 2008; Stenman et al., 2008; Wang et al., 2012) . Mice with endothelial-specific β-catenin mutations have overtly normal vasculature in peripheral tissues but have major vascular defects in the CNS, including a lack of capillaries, thickening of the vascular plexus and hemorrhagic malformed vessels within the CNS (Daneman et al., 2009) . Moreover, the malformed vessels lack BBB specific properties including the expression of glut-1 (Daneman et al., 2009; Stenman et al., 2008) . Liebner et al. also reported that β-catenin inactivation leads to a down-regulation of claudin-3, a component of the paracellular tight junctions, and up-regulation of plasmalemma vesicle-associated protein (PLVAP), which increases the transcellular vesicle trafficking leading to an increase permeability of the BBB to plasma proteins. They also observed in vitro that the treatment of endothelial cells with Wnt3a conditioned medium leads to an increase of claudin-3 expression (Liebner et al., 2008) . Moreover addition of Wnt ligand to endothelial cells led to an increase in expression of BBB specific transporters including glut-1, cat1 and lat1 (Daneman et al., 2009 ). These experiments suggest that Wnt is important for driving angiogenesis into the CNS and also inducing barrier properties.
Interestingly, different Wnt ligands, Frizzled receptors and coreceptors are expressed in spatially distinct regions within the CNS, and genetic analysis has clearly demonstrated that different family members are required for CNS-angiogenesis and BBB induction in different regions of the CNS. Wnt proteins have different patterns of expression throughout the CNS: Wnt1, Wnt3, Wnt3a and Wnt4 have been observed in dorsal regions while Wnt7a and Wnt7b are expressed in ventral regions (Daneman et al., 2009) . CNS endothelial cells also express different Frizzled receptors, including Frizzled 4, Frizzled 6 and Frizzled 8 (Daneman et al., 2009 ).
Wnt7a and Wnt7b have been identified to be essential for the development of ventral CNS vasculature and acquisition of the BBB phenotype within these vessels (Daneman et al., 2009; Stenman et al., 2008) . Stenman et al. observed that mice lacking both Wnt7a and Wnt7b have neural tube hemorrhages as ventral blood vessel development is altered, with these vessels expressing lower levels of GLUT1 (Daneman et al., 2009; Stenman et al., 2008; . Norrin signaling through Frizzled 4 is required for retinal angiogenesis and defects in this pathway lead to retinal diseases including the Norrie disease and familial exudative vitreoretinopathy (Junge et al., 2009; Paes et al., 2011; Wang et al., 2012; Ye et al., 2009) . Norrin is a TGF-beta family member with no homology to any Wnt ligands, but is able to active Frizzled4 and induce canonical Wnt signaling, suggesting a unique mechanism for activation of Wnt/beta-catenin pathway within retinal vessels. Out of the 10 mammalian Frizzled receptors, Fizzled 4 is the only Frizzled receptor for Norrin (Smallwood et al., 2007) . Loss of either Norrin or Fzd4 leads to major retinal vascular defects including reduction in capillaries, vascular malformations, loss of venous cell fate, and leakiness of the blood-retinal barrier (Wang et al., 2012) . In addition, Fzd4 null mice show an increase in BBB permeability in the olfactory bulb, spinal cord and cerebellum. The more widespread phenotype of Fzd4 mutants as compared to the Norrin mutants suggests that Fzd4 may also be activated by other Wnt ligands in these regions. Loss of Fzd4 leads to an increase of PLVAP and decrease of claudin-5, suggesting that this signaling is required to restrict both the transcellular and paracellular pathways (Wang et al., 2012) .
In addition, different Wnt/Fzd co-receptors have been identified in spatially distinct regions. Gpr124, a member of the adhesion family of the G protein-coupled receptors, is expressed by BECs and pericytes and is essential for both ventral CNS angiogenesis and the acquisition of BBB properties in these vessels (Anderson et al., 2011; Cullen et al., 2011; Kuhnert et al., 2010) . Gpr124 null embryos displayed CNS vascular abnormalities including reduced vascular sprouting into the forebrain telencephalon and these mice die at E15.5 from with hydrocephaly and hemorrhages within the forebrain (Anderson et al., 2011; Cullen et al., 2011; Kuhnert et al., 2010) . The pattern of vascular defects within the brain of Gpr124 −/− is very similar to that of (Daneman et al., 2009; Stenman et al., 2008; . Recent work has identified that Gpr124 is a co-activator specifically of Wnt7a and Wnt7b required to induce canonical Wnt signaling pathway via Frizzled4 . Using transfection of a canonical Wnt reporter cell line, Zhou et al. examined Norrin and the 19 mammalian Wnt proteins and observed that Gpr124 enhanced canonical Wnt signaling by~8 and~4 fold for Wnt7a and Wnt7b. The authors did the same experiment for the ten Frizzled receptors and found that Gpr124 specifically increased Frizzled4 signaling~10 fold. Interestingly, Tspan12 appears to be a similar co-receptor required for Norrin/Fzd4 function, and loss of function of Tspan12 leads to retinal vascular defects and an increase in blood-retinal barrier permeability (Junge et al., 2009 ). It has also been shown that Wnt/beta-catenin signaling is required to maintain BBB integrity throughout life. Fzd4 deletion or the administration of anti-Frizzled 4 blocking antibody in adult mice leads to an increase PLVAP expression and BBB/blood-retinal barrier (BRB) permeability (Paes et al., 2011; Wang et al., 2012) and deletion of the expression or mutation of Norrin or Fzd4 lead to the same abnormal retinal vascular development in mice (Junge et al., 2009; Ohlmann and Tamm, 2012; Wang et al., 2012; . Thus, activation of Wnt signaling is not only important for induction of BBB properties during development, but also maintenance of these properties in adulthood. Interestingly, it appears that Wnt ligands are supplied by neural progenitors during embryogenesis but then secreted by astrocytes during postnatal development and adulthood. Mosaic studies have identified that canonical Wnt signaling is required in a cell autonomous manner: activation of Wnt/beta-catenin signaling leads to a 'tight' phenotype within a given cell in part by inducing TJ proteins such as claudin-5 and also by repressing PLVAP (Wang et al., 2012) . Interestingly, studies using PECs suggest that nuclear β-catenin can also have opposite effects and may act to increase vascular permeability by working in conjunction with FoxO1 to inhibit the expression of claudin-5 . This seemingly contradictory result may be due to different roles of β-catenin in endothelial cells derived from different tissues, or may indicate a much more complex role of β-catenin in regulating vascular permeability that potentially involves different functions based on the relative levels of β-catenin activation.
Since canonical Wnt signaling is required for CNS-angiogenesis and BBB development, the identification of downstream Wnt/beta-catenin targets is needed to understand how those processes are initiated and regulated. Tam et al. identified that DR6 and TROY, two TNF receptor superfamily members, are induced in CNS endothelial cells by Wnt signaling and regulate angiogenesis and barriergenesis (Tam et al., 2012) . Using in vitro sprouting assays, DR6 and Troy were shown to be required for vascular sprouting by inducing angiogenesis via VEGFmediated JNK activation. Experiments in both zebrafish and mice have identified that DR6 and TROY are also needed for BBB function. In zebrafish, morpholino-mediated knockdown of dr6 and troy led to BBB leakage of exogenous tracers including DAPI and a 10 kDa rhodamine-dextran. In addition, Dr6 null and endothelial cell-specific Dr6 conditional knockout mice also displayed BBB leakage to a sulfo-NHSbiotin molecular tracer and developed forebrain hemorrhages during development, and both Dr6 and Troy knockout mice displayed BBB leakage to Evans Blue as adults. Moreover, both complete and endothelialspecific Dr6 knockout mice showed a reduction of the tight junction component ZO-1 in CNS endothelial cells, however, neither Dr6 nor Troy deletion affected glut-1 expression in CNS-vessels. These results suggest that induction of these TNF receptor superfamily genes in is required to mediate some, but not all, aspects of Wnt signaling in CNS endothelial cells Taken together these data suggest that there is an CNS-specific angiogenic program required to drive angiogenesis into the developing neural tissue, and this same pathway also induces and maintains BBBspecific properties including inducing the expression of 'tight properties' including TJs and nutrient transporters and suppressing 'leaky' transcellular trafficking properties. Interestingly, the angiogenic defects of Wnt mutants can be rescued by expression of a constitutively active beta-catenin, suggesting that Wnt is not providing a directional cue, but perhaps a motility cue. Several questions still remain: Does Wnt regulate all the different properties of the BBB ? If there are Wnts in all tissues, why is this cascade only activated in CNS endothelial cells? How does Wnt interact with other angiogenic cues such as VEGF? Wnt activation is decreased during development, does this imply a different Wnt-related mechanism for induction and maintenance of the BBB?
Pericyte-regulated BBB properties
Recent work using pericyte-deficient mice has shown that these cells are important for the development and maintenance of the BBB. Pericytes and vascular smooth muscle cells (VSMCs) are mural cells that sit on the abluminal surface of microvascular and large vessel tubes respectively. During sprouting angiogenesis, platelet-derived growth factor B (PDGF-B) is secreted by endothelial cells to recruit pericytes (Andrae et al., 2008; Bjarnegård et al., 2004; Enge et al., 2002; Hellström et al., 1999) . PDGFB is not only needed for pericyte recruitment but also necessary for their proliferation, migration and attachment to the cerebral endothelium (Winkler et al., 2011) . In the CNS, pericytes are recruited to the vasculature within a day of angiogenic invasion into the CNS, a time coinciding with sealing of the BBB. Using Pdgfr-β mutant mice, which completely lack CNS pericytes, it has been shown that the BBB fails to seal and is leaky to molecular tracers of different sizes (Armulik et al., 2010; Daneman et al., 2010b) . Analyzing different properties of the BBB it was identified that pericytes were not required to induce the expression of 'tight' properties such as TJ or transporters, but were vital to inhibit 'leaky' properties including suppression of transcytosis and LAM expression (Armulik et al., 2010; Daneman et al., 2010b) . This fits with the timing of pericyte recruitment to the angiogenic vessels, as the initial endothelial cells have leaky properties, including high rates of transcytosis and the expression of LAMS, which are then reduced within the days following pericyte recruitment.
Pericytes are present on vessels in all tissues, therefore an important question is why pericytes regulate BBB properties in BECs. One possibility is that pericytes regulate vascular permeability in all tissues, but that in the CNS the endothelial cells have been induced to differentiate into brain-specific endothelial cells by other signals including Wnts. In this model the pericytes in all tissues are the same, but the canvas of the endothelial cell would then determine the permeability the vessel. Another possibility is that pericytes in the brain have different functions than pericytes in other tissues. In line with this argument is the finding that brain pericytes have a different origin, the neural crest, than pericytes in many peripheral tissues, and thus could have completely different functions (Korn et al., 2002) . Counter to this argument is finding that the CNS pericytes come from two different lineages. Forebrain pericytes are derived from the neuroectoderm of the neural crest whereas pericytes present in the midbrain, brain stem and spinal cord originate from the mesoderm (Etchevers et al., 2001; Korn et al., 2002; Kurz, 2009; Winkler et al., 2011) . It will be interesting to identify the secretome of pericytes from different tissues to determine if CNS pericytes, but not pericytes in non-neural tissues, secrete barrier inducing molecules. A third option is that the vascular coverage of pericytes determines the permeability. CNS vessels have the highest pericyte coverage of any tissue in the body: the BEC-pericytes ratio is estimated to be between 3:1 and 1:1 (Mathiisen et al., 2010; Sims, 1986) , whereas in other tissues it can be as high as 100:1 (Díaz-Flores et al., 2009; Shepro and Morel, 1993) . Several studies have addressed whether pericyte number could be an important component. Using mice containing hypomorphic alleles of Pdgfb or Pdgfrβ which have fewer pericytes than normal, it has been observed that pericyte coverage is inversely proportional to vascular permeability (Armulik et al., 2010; Daneman et al., 2010b) . Thus, it is not just the presence of pericytes that is important but the total number of pericytes is important in determining the permeability of the vessels, both during development of the BBB, maintenance in adulthood, and during aging (Armulik et al., 2010; Bell et al., 2010; Daneman et al., 2010b) . Recently, it was identified that Wnt signaling induces the expression of PDGF-B in CNS endothelial cells, suggesting that the CNS-specific angiogenic program may also regulate the amount of pericytes recruited to the vessels (Reis et al., 2012) .
Interestingly, different mutations affecting the PDGFB-PDGFRβ pathway lead to different BBB phenotypes. Mutations in tyrosine phosphorylation sites on PDGFRβ lead to decreased signaling and mice with these mutations have lower pericyte recruitment and a leaky BBB during development and aging, but are relatively normal in adulthood (Bell et al., 2010; Daneman et al., 2010b) . Mice with mutations in the ECM-retention motif of PDGFB also have lower pericyte recruitment, but these mice show much more severe BBB disruption throughout life, defects in astrocyte endfeet recruitment and calcification of the brain (Armulik et al., 2010; Keller et al., 2013) . The difference in the phenotypes could result from a difference in the total number of pericytes in each genetic model, or the fact that the removal of the ECM-retention motif of PDGFB leads to mis-localization of this growth factor signaling which could lead to neomorphic phenotypes. Interestingly, Siegenthaler et al. showed that increasing the number of pericytes can also lead to BBB leakage. They demonstrated that FoxC1 is expressed by brain pericytes, and that deletion of this transcription factor leads to an increased number of pericytes and focal BBB leakage (Siegenthaler et al., 2013) . This data suggests that the exact number of pericytes is important for the normal permeability of the BBB, and that either increases or decreases in the number of pericytes can lead to BBB dysfunction.
While it is clear that pericytes are important to regulate the formation and function of the BBB, the molecular mediators of this interaction remain unknown. TGF-β has been identified as a potential pericytesecreted factor that regulates BBB tightness. Doghu et al. have demonstrated that when MBEC4 cells were co-cultured with rat pericytes in vitro they observed a decrease in the permeability for both Sodium fluorescein and the Pgp substrate Rhodamine123 suggesting that pericytes limit the paracellular permeability and regulate efflux transport. This decrease in permeability could be reversed by inhibiting TGF-β signaling by using either a TGF-β antibody or a TGFβR1 antagonist (Dohgu et al., 2005; Kim et al., 2003) . More studies are needed to clearly identify how pericyte-derived TGF-β modulates the BBB in vivo. In addition, it has been identified that pericytes secrete different ECM factors that could influence vascular integrity (Siegenthaler et al., 2013) .
Astrocyte regulation of BBB properties
Astrocytes are a glial cell that extends polarized cellular processes that ensheath both neuronal processes (synapses or nodes of ranvier) and blood vessels. These cells have many functions in the brain including neurotransmitter uptake, supporting neuronal metabolism, regulating ion concentration within the extracellular space, CNS repair after injury, regulating vascular tone in response to neuronal activity and maintenance of the blood-brain barrier phenotype.
Due to the fact that astrocytes ensheath blood vessels many studies have focused on the role of astrocytes in inducing the BBB. Indeed, initial studies suggested that astrocytes are capable of BBB induction. Transplantation of astrocytes into non-neural tissues such as the anterior chamber of the eye or the chick chorioallantoic membrane, induced barrier properties in these normally leaky endothelium (Janzer and Raff, 1987) . Furthermore, BBB in vitro models have been developed by adding astrocytes or astrocyte-conditioned media to CNS endothelial cells to induce a BBB phenotype including an increase in TEER and TJ protein expression, cell polarization and increased expression of specific transporters such as GLUT1 and PGP (Deli et al., 2005; Gaillard et al., 2000; Hayashi et al., 1997; Helms et al., 2012; Nishitsuji et al., 2011; Rubin et al., 1991; Sobue et al., 1999; Wosik et al., 2007) .
Recent evidence however, has demonstrated that many of the BBB properties are induced during embryogenesis prior to astrocyte generation and ensheathment of the vessels. Astrogliogenesis occurs between E18 and P7 in rodent cerebral cortex and BBB properties are observed as soon as E15, suggesting that astrocytes cannot be the cell type that induces the BBB (Ben-Zvi et al., 2014; Daneman et al., 2010b; Sauvageot and Stiles, 2002; Sohet et al., 2015; Tien et al., 2012) . Several, possibilities exist for this apparent contradiction. First, astrocyte cultures that have been utilized may not be pure astrocyte populations but contain other cell types including neural progenitors and pericytes. Indeed, astrocyte cultures are generated from early postnatal brains and consist of dividing cell populations and not solely post-mitotic astrocytes.
These cells may act more like progenitors or reactive astrocytes cells than astrocytes in a normal adult healthy brain. Another possibility is that astrocytes aren't required for BBB induction, but for the maintenance of the BBB. Support for this idea is derived from the fact that astrocytes are able to induce a BBB-phenotype in endothelial cells derived from the CNS but not peripheral tissues, indicating that a previous induction signal may be required. A third possibility is that through the course of development astrocytes take over the role of neural progenitors in regulating properties of the BBB. In this model during early embryogenesis when progenitors are abundant and astrocytes are absent, the former regulates the formation and function of the BBB, but in postnatal periods when progenitors are sparse and astrocytes are abundant, the latter plays the same role. Support for this comes with the identification that Wnt/beta-catenin signaling is not only required for BBB induction but also BBB maintenance and that astrocytes may be the providers of the secreted ligands in postnatal periods. This suggests that astrocytes are indeed important for secreted signals required for the maintenance of the BBB. In addition to Wnts, several other astrocyte-derived signals have been identified that regulate BBB function, including Sonic hedgehog, angiopoietins, angiotensin, and ApoE.
Sonic hedgehog (SHH) has a major role in the morphogenesis of many tissues. SHH is one of the three proteins of the hedgehog protein family which also includes Desert hedgehog (DHH) and Indian hedgehog (IHH). SHH binds and inhibits the receptor Patched (PTCH) causing de-repression of Smoothened (SMO) leading to the activation of the Gli zinc-finger transcription factor family (Ruiz i Altaba et al., 2002; Varjosalo and Taipale, 2008) . The secretion of SHH by astrocytes regulates the BBB phenotype by affecting two distinct characteristics. First, SHH regulates brain immune quiescence by lowering the levels of the LAM Icam1, impeding immune cell infiltration through the BBB (Alvarez et al., 2011) . Second, SHH seals paracellular space to limit paracellular diffusion. Alvarez et al. observed a significant increase of occludin and claudin-5 when human BECs were cultured with astrocyte conditioned medium or human recombinant SHH in vitro, and a decrease in these molecules in Shh mutant mice in vivo.
It has been demonstrated that SSeCKS, a src-suppressed C-kinase substrate, is expressed in astrocytes and it increases angiopoietin (ANG-1) expression via the reduction of the transcription factor activator protein 1 (AP-1) activity . ANG1 is an agonist of the TIE2 receptor, and activation of this receptor leads to decreased vascular permeability in vessels throughout the body. Indeed, an important increase of the expression of many tight junction proteins such as ZO-1 and claudin-1 and a decrease in the permeability of [ 3 H]sucrose are observed when HBMECs are fed SSeCKS-overexpressing astrocyte conditioned medium .
Angiotensinogen (AGT) is the precursor of angiotensins I-IV, which are generated by the proteolytic cleave of the secreted AGT protein.
There are also four angiotensin receptors: AT 1 , AT 2 , AT 3 , and AT 4 that are G protein-coupled receptors. Angiotensinogen is secreted by astrocytes, cleaved into angiotensin II and bind to AT 1 expressed by BECs (Wosik et al., 2007) . Wosik et al. demonstrated that Agt knockout mice have disorganized occludin within the tight junctions of the BBB resulting in a leaky BBB that is permeable to plasma proteins.
Apolipoprotein E (ApoE) secreted lipoparticles also appear to be important for regulation of tight junction integrity at the BBB. ApoE knockout mice display an age-related increase in BBB permeability, and it has been further shown that different alleles present in human populations can affect this process in different ways (Bell et al., 2012) . ApoE4-knock in mice display a greater BBB permeability than ApoE3-knock in mice, suggesting that the increased Alzheimer's disease risk in people with APOE4 may be due to neurovascular deficits (Bell et al., 2012) . ApoE is secreted by astrocytes and acts on BECs through Lrp1. Using a triple co-culture in vitro BBB model combining endothelial cells and pericytes from wild type mice and primary astrocytes from ApoE3-and ApoE4-knock in mice, Nishitsuji et al. observed an important reduction of PKCη and occludin phosphorylation in ApoE4-versus ApoE3-knock in BBB in vitro model (Nishitsuji et al., 2011) . TEER was also reduced in ApoE4-knock in BBB model compared to ApoE3 and WT.
Taken together these data suggest that astrocytes play an important role in regulating the function of the BBB by secreting a series of different proteins that affect the phenotype of BECs. There are several important questions that still need to be addressed: Do each of these signals regulate all properties of the BBB or does each signal regulate distinct properties of the BBB? How are each of these different signals coordinated to regulate the different properties of the BBB? Are these signals dynamically modulated in response to external cues? How are these signals disrupted during neurological disease? How do pericyte and astrocytes interact to regulate the BBB in adulthood?
The extracellular matrix
The extracellular matrix (ECM) is often an underestimated regulator of BBB properties. The ECM is secreted by BECs, pericytes, and astrocytes, and is composed of a multitude of structural proteins including collagens, fibronectin, laminins, heparin sulfate proteoglycans and chondroitin sulfate proteoglycans (Correale and Villa, 2009 ). There are two basement membranes at the BBB: the vascular basement membrane secreted by BECs and pericytes, and the glial basement membrane secreted by astrocytes. The ECM provides structural support for the vessels, a scaffold for growth factors such as PDGF-BB, VEGF, and TGF-β, and provides a physical barrier for leukocyte migration into the parenchyma.
The basement membrane also regulates BBB permeability. Osada et al. demonstrated that endothelial cell adhesion to the ECM by β 1 -integrins increases claudin-5 expression (Osada et al., 2011) . Moreover, Menezes et al. observed that Lama2-null mice display an increase in BBB permeability compared to wild-type littermates which correlated with a lower pericyte and astrocytic endfeet coverage, a lower expression of VE-cadherin, claudin-5 and occludin and an increase of PLVAP expression (Menezes et al., 2014) . Thus the ECM appears to be a central scaffold linking different cells and molecules of the NVU. Yao et al. recently demonstrated that astrocytic laminin is required for pericyte differentiation, polarization of astrocytic endfeet and maintenance of BBB properties (Yao et al., 2014) . More precisely, viral abrogation of astrocytic laminin in mice leads to a decrease of occludin, claudin-5 and aquaporin-4. While performing in vitro studies in which pericytes were plated on astrocytic laminin (laminin 111), they demonstrated that pericyte differentiation was mediated by integrin α2.
Peripheral signals inducing BBB properties
While much work has concentrated on the role of neural derived signals regulating the formation and function of the BBB, several peripheral signals have been identified as modulators of this barrier. Blood flow induces a mechanical stimulation on endothelial cells called shear stress. Using an in vitro BBB model with and without shear stress, Cucullo et al. demonstrated that shear stress aided in the acquisition of BBB properties by endothelial cells. Indeed, in a BBB in vitro model, the RNA of many tight junction proteins (ZO-1, claudin-3 and claudin-5), drug and metabolic transporters (Pgp, Abcc1, glut-1) were upregulated by addition of a shear stress component (Cucullo et al., 2011) .
The gut flora also appears to have a role in the induction of BBB properties. In the absence of a normal gut flora (microbiota) in the mother, the expression of BEC claudin-5 and occludin is diminished and an increase in BBB permeability is observed in pups (Braniste et al., 2014) . The monocolonization with Clostridium tyrobutyricum or Bacteroides thetaiotaomicron, or treatment with bacterial metabolites (short chain fatty acids (SCFAs): butyrate, acetate, propionate) of germ-free mice lead to a suppression of this BBB permeability and an increase TJs protein expression. The mechanism by which the microbiota has an effect on the BBB permeability is not clear yet. Is the placenta permeable to SCFAs, such that SCFAs act directly on the embryos? If not, does the microbiota affect the placenta and then the placenta sends signals to the developing BBB? Could it be possible that this could induce epigenetic modifications that will be translated later in neurological diseases during adulthood or aging? This hypothesis is interesting to investigate as Braniste et al. observed that sodium butyrate administration or colonization with C. tyrobutyricum of free-germ mice lead to an increase of histone acetylation (Braniste et al., 2014) .
Conclusion
The development of the BBB requires the regulation of multiple pathways activated by a variety of signals. These pathways masterfully regulate the induction and maintenance of BBB properties in a specific spatial-temporal sequence. It appears that this is a complex process that involves the interaction of BECs with a number of different cell types including neural progenitors, pericytes, astrocytes as well as different environmental cues. The multi-step process appears to initiate with neural precursor derived Wnt-mediated induction of BBB properties during the angiogenic program, and further modulation of these properties by pericytes, astrocytes and environmental cues. While individual cellular and molecular interactions have been identified, it is critical to determine how each of the different signals is coordinated during BBB development to regulate the different features of the BBB. It will also be interesting to determine if there are differences in BBB gene expression and function in different brain regions or parts of the vascular tree, how those differences may be induced during development, and whether they are important for the function of the brain. Finally, it will be very exciting to determine whether these properties of the BBB are dynamic and whether they are altered by neuronal activity, diet or other environmental cues. A greater knowledge of the mechanisms involved in the development of the BBB might give cues to orientate research based on BBB alterations related to CNS disorders.
